Ticker Details
OPKO Health, Inc. OPKO Health Inc is a diversified healthcare company. Its business includes diagnostics and provision of pharmaceutical products.
IPO Date:	November 2, 1995
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$958.97M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 2.72%
Avg Daily Range (30 D):	$0.02 | 1.84%
Avg Daily Range (90 D):	$0.02 | 1.96%

Institutional Daily Volume
Avg Daily Volume:	3.28M
Avg Daily Volume (30 D):	2.07M
Avg Daily Volume (90 D):	2.28M

Trade Size
Avg Trade Size (Sh.):	298
Avg Trade Size (Sh.) (30 D):	247
Avg Trade Size (Sh.) (90 D):	302

Institutional Trades
Total Institutional Trades:	4,511
Avg Institutional Trade:	$1.81M
Avg Institutional Trade (30 D):	$.79M
Avg Institutional Trade (90 D):	$.94M
Avg Institutional Trade Volume:	.39M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.99M
Avg Closing Trade (30 D):	$.55M
Avg Closing Trade (90 D):	$.89M
Avg Closing Volume:	452.62K

News

Feb 12, 2026 @ 1:00 PM OPKO Health to Report Fourth Quarter 2025 Financia... Source: Na

Feb 4, 2026 @ 1:00 PM OPKO Health and Entera Bio Expand Partnership to A... Source: Opko Health, Inc. And Entera Bio Ltd.

Nov 18, 2025 @ 1:00 PM Entera Bio to Participate in the 8th Annual Everco... Source: Miranda Toledano

Oct 8, 2025 @ 12:02 PM NextPlat Issues CEO Shareholder Update Letter Source: David Phipps

Aug 8, 2025 @ 9:17 PM Entera Bio Beats Q2 EPS Estimates Source: Jesterai

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.27	$-.07	$-.04
Diluted EPS	$-.27	$-.07	$-.04
Revenue	$581.12M	$124.2M	$148.45M
Gross Profit	$209.08M	$45.76M	$64.03M
Net Income / Loss	$-212.92M	$-54.85M	$-31.26M
Operating Income / Loss	$-101.26M	$-51.02M	$-38.32M
Cost of Revenue	$372.05M	$78.44M	$84.43M
Net Cash Flow	$-94.52M	$-26.27M	$-46.31M
PE Ratio